Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Janeiro 2024 - 10:30AM
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading
radiopharmaceutical-focused company committed to enabling
clinicians to Find, Fight and Follow disease to deliver better
patient outcomes, today announced Mary Anne Heino, Chief Executive
Officer, will present at the 42nd Annual J.P. Morgan Healthcare
Conference at 11:15 a.m. PST on Wednesday, January 10.
To access a live webcast of the presentation, please visit the
Investors section of the Company’s website at www.lantheus.com. A
replay of the webcast will be available on the Company’s website
for at least 30 days following the live presentation.
About Lantheus Lantheus is the leading
radiopharmaceutical-focused company, delivering life-changing
science to enable clinicians to Find, Fight and Follow disease to
deliver better patient outcomes. Headquartered in Massachusetts
with offices in New Jersey, Canada and Sweden, Lantheus has been
providing radiopharmaceutical solutions for more than 65 years. For
more information, visit www.lantheus.com.
Contacts:Mark KinarneyVice President, Investor
Relations978-671-8842ir@lantheus.com
Melissa Downs Senior Director, External
Communications646-975-2533media@lantheus.com
Lantheus (NASDAQ:LNTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Lantheus (NASDAQ:LNTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024